Clinical Trial Update: A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD6793

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: RECRUITING